Table 2. Methods, tissues and genomic regions used for virus detection.
Viruses | Nucleic acid | Kit used for amplification | Type ofPCR | Genomic region Targeted | Size of the amplicon | Tissue | Reference |
CPV/FPLV | DNA | Fast start Master Mix, Roche | real-time | vp2 gene | 93 bp | small intestine lymph nodes | [46] |
FCoV/CCoV | RNA | One-step RT-PCR, Qiagen | real-time | 7b gene | 102 bp | small intestine lymph nodes | [41] |
CDV | RNA | One-step RT-PCR, Qiagen | real-time | N gene | 161 bp | lungs | in house (not published) |
ADV | DNA | Fast start Master Mix, Roche | real-time | gB gene | 94 bp | lungs | [42] |
CAV-1 | DNA | High Fidelity Master Mix, Roche | conventional | E3 gene | 508 bp | liver | [43] |
CAV-2 | DNA | High Fidelity Master Mix, Roche | conventional | E3 gene | 1030 bp | lungs | [43] |
FHV | DNA | High Fidelity Master Mix, Roche | real-time | TK gene | 56 bp | lungs | [44] |
Influenza A | RNA | One-step RT-PCR, Qiagen | real-time | Matrix gene | 100 bp | lungs | [45] |